Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia.
van Balkom
A J
AJ
Department of Psychiatry, Institute for Research in Extramural Medicine, Vrije Universiteit, Amsterdam, The Netherlands.
de Beurs
E
E
Koele
P
P
Lange
A
A
van Dyck
R
R
D000293:Adolescent; D000328:Adult; D000368:Aged; D000379:Agoraphobia / Q000453:epidemiology / Q000523:psychology / Q000628:therapy*; D000704:Analysis of Variance; D001521:Behavior Therapy; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D015897:Comorbidity; D003866:Depressive Disorder / Q000175:diagnosis / Q000453:epidemiology; D004311:Double-Blind Method; D016666:Fluvoxamine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D016584:Panic Disorder / Q000453:epidemiology / Q000523:psychology / Q000628:therapy*; D010555:Personality Inventory; D010919:Placebos; D011336:Probability; D012720:Severity of Illness Index; D016896:Treatment Outcome
D010919:Placebos; D001569:Benzodiazepines; D016666:Fluvoxamine